Therapy of acute leukemia: contribution of the new anthracyclinic drugs
Lambertenghi-Deliliers, G.; Colajori, E.; Annaloro, C.; Polli, E.E.
Recenti Progressi in Medicina 76(7-8): 392-397
1985
ISSN/ISBN: 0034-1193 PMID: 3906794 Document Number: 254021
Document emailed within 1 workday
Related Documents
Hartwich, G.; Brandt, W.; Petzoldt, R. 1975: Results of therapy in acute leukemia in adults. Comparison of different combinations of cytotoxic drugs Medizinische Klinik 70(14): 622-625Klimenko, V.I.; Romanova, A.F.; Zverkova, A.S.; Evtukh, V.P. 1988: Results of the treatment of acute leukemia in relation to the sensitivity of leukemia cells to cytostatic drugs Vrachebnoe Delo 6: 86-88
Van den Akker, J.; Pérot, C.; Portnoï, M.F.; Philizot, L.; Dupont, J.M.; Laporte, J.P.; Taillemite, J.L. 1995: Translocation t(6;9;8)(p23;q34;q22) in acute myeloid leukemia: Contribution of fluorescence in situ hybridization Annales de Genetique 38(3): 168-171
Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Levy, A.; Pinkhas, J. 1983: Prognostic factors and new drugs in acute non-lymphoblastic leukemia Harefuah 105(8): 236-238
Nawata, R.; Shinohara, K.; Yamada, T.; Takahashi, T.; Katsuki, K.; Takeda, K.; Kameda, N.; Ariyoshi, K.; Ota, I.; Muraki, K. 2000: Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses International Journal of Hematology 71(4): 353-358
Furuta, T.; Yokokura, T. 1991: Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(3): 393-402
Zhu, H.; Zhang, J. 1993: Treatment of stomatological complications in 31 cases of acute leukemia with Chinese herbal drugs Journal of Traditional Chinese Medicine 13(4): 253-256
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Wolowiec, D.; Ffrench, M.; Tigaud, J.D.; Treille-Ritouet, D.; Archimbaud, E.; Bryon, P.A. 1988: DNA, RNA, and protein content in adult acute myeloid leukemia: effects of cytostatic drugs in vivo Leukemia 2(8): 534-539
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Kuliszkiewicz-Janus, M. 1984: Differences in the blast cells sensitivity to cytostatic drugs in various acute leukemia types and their clinical implications Neoplasma 31(3): 291-298
Ishikawa, M.; Nakayama, K.; Rahman, M.T.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Nakayama, N.; Miyazaki, K. 2014: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report European Journal of Gynaecological Oncology 35(4): 443-448
Gross, R.; Borberg, H.; Dietrich, M.; Köhle, K.; Landbeck, G.; Löffler, H.; Schmidt, C.G.; Stacher, A.; Wilmanns, W. 1973: Therapy of acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 339-340
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Gale, R.P.; Foon, K.A. 1987: Therapy of acute myelogenous leukemia Seminars in Hematology 24(1): 40-54
Manabe, A.; Yi, T.; Kumagai, M.; Campana, D. 1993: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia Leukemia 7(12): 1990-1995
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449